Introduction {#s1}
============

Epilepsy and attention deficit hyperactivity disorder (ADHD) have significant effects on the social and behavioral development of children [@pone.0057926-Williams1]. Epilepsy is characterized by spontaneous recurrent seizures [@pone.0057926-Aicardi1], but can be a pervasive condition of which seizures are one expression [@pone.0057926-Aicardi2]. Similarly, ADHD has severe and persistent symptoms, such as inattention, over-activity, and impulsiveness, which initially manifest in early childhood but are associated with long-term educational and social disadvantages [@pone.0057926-Swanson1].

Previous research has indicated that ADHD is the most common disorder in preschool and school-aged children with epilepsy [@pone.0057926-ThomeSouza1]. Behavioral difficulties in epileptic children suggest a high risk for ADHD [@pone.0057926-Holdsworth1], [@pone.0057926-Stores1]. Similarly, 6.1% of ADHD children have abnormal electroencephalograph (EEG) results, compared to only 3.5% of healthy children [@pone.0057926-Richer1]. Previous research [@pone.0057926-Austin1], [@pone.0057926-Dunn1] on children with unprovoked seizures shows that behavioral disturbances are more common before the onset of the first seizure compared to controls. A larger study involving 148 children with first unprovoked seizures and 89 seizure-free sibling controls shows that attention problems before the first seizure, as assessed by the Child Behavior Checklist, are 2.4-fold more common in children with seizures (8.1%) than in controls (3.4%) [@pone.0057926-Austin1].

Whether ADHD is a non-specific symptom caused by anti-epileptic drugs (AEDs), non-convulsive epileptiform discharges, or negative chronic seizure effects remains unknown. Whether ADHD is associated with epilepsy because of overlapping pathophysiologic mechanisms is also unclear. Comorbidity patterns that show shared neurobiological mechanisms involved in multiple disorders may provide useful insights.

Researchers previously conducted a two-way population-based retrospective cohort study to determine the possibility of developing schizophrenia in patients with epilepsy, and vice versa [@pone.0057926-Chang1]. That study shows a strong bidirectional relationship between schizophrenia and epilepsy. Therefore, we hypothesize that ADHD increases the risk of subsequent epilepsy and vice versa. We conducted this study to evaluate any bidirectional correlation between ADHD and epilepsy by using 2 cohorts from the same population base.

Materials and Methods {#s2}
=====================

Data Source {#s2a}
-----------

The Taiwan National Health Insurance Research Database (NHIRD), an electronic claims database of the Taiwan National Health Insurance (NHI) program, covers 99% of the 23 million population of Taiwan and contracts with more than 90% of national health care facilities [@pone.0057926-NHI1], [@pone.0057926-Lu1]. We analyzed an NHIRD data set of 1 million patients randomly selected from people insured in 2000. Medical claims data during the period 1996--2008 were available for all insurants. Using this data set, we obtained longitudinal person-level data on medical care usage by linking an encrypted but unique personal identification from 3 files: registry for beneficiaries, ambulatory care claims, and in-patient claims. We confirmed that all data were analyzed anonymously. This study was also approved by the Ethics Review Board at China Medical University (CMU-REC-101-012).

Study Design and Patients {#s2b}
-------------------------

We conducted 2 cohort studies to assess whether epilepsy \[International Classification of Disease, Ninth Revision (ICD-9), Clinical Modification, code ICD-9 345\] is associated with the subsequent incidence of ADHD (ICD-9 codes 314.00, 314.01) (Cohort 1) or vice versa (Cohort 2) by using the same procedure to select the study participants ([Fig. 1](#pone-0057926-g001){ref-type="fig"}). The study sample consisted of children below 19 years of age without mental retardation (ICD-9 317--319). Cohort 1 included children initially diagnosed with epilepsy from 1999--2008 and a non-epileptic comparison group from the same period, excluding those with an ADHD history. Cohort 2 included children newly diagnosed with ADHD during the same period (1999--2008) and a non-ADHD comparison group, excluding those with prior epilepsy. The index date was the date of diagnosis with epilepsy (Cohort 1) or ADHD (Cohort 2). We randomly selected comparison groups in the 2 cohorts matched based on age, sex, and index year. The comparison-to-patient ratio in the group was 4.

![Schematic diagram of the selection of study subjects.](pone.0057926.g001){#pone-0057926-g001}

A diagnosis of outpatient and inpatient claims revealed the onset of ADHD and epilepsy for Cohorts 1 and 2, respectively, during the follow-up period. This period started from the index date and terminated on the date of cancellation of the insurance coverage or December 31, 2008 (whichever came first).

Statistical Analysis {#s2c}
--------------------

We performed all statistical analyses using SAS (version 9.1 for Windows; SAS Institute Inc., Cary, NC, USA). In Cohort 1, we compared the differences in demographic characteristics, including age, sex, and urbanization level of the residential area, between patients with epilepsy and the comparison group by using chi-square and Wilcoxon two-sample tests for categorical and continuous variables, respectively. We used Cox proportional-hazards regression models to estimate hazard ratios (HRs) and their 95% confidence intervals (95% CI) for ADHD incidence in patients with epilepsy in a relationship to the comparison group. Accessibility to health care varies among geographic regions in Taiwan, requiring the adjustment of the urbanization level in the multivariate models. We repeated Cox regression analyses in subgroups stratified by age and sex. We used the same statistical analysis in Cohort 2. All significance levels were set as a two-sided *P*\< .05.

Results {#s3}
=======

Cohort 1: Epilepsy and Subsequent Risk of ADHD {#s3a}
----------------------------------------------

Cohort 1 included 2468 epileptic and 9810 non-epileptic children ([Table 1](#pone-0057926-t001){ref-type="table"}) matched for age and sex. Among the epileptic patients, 43.8% were aged \<6 years, 31.0% were 6--12 years, and all others were \>12 years. The mean age (±SD) was 8.0 ± 5.3 years. Approximately 44% of the cohort comprised girls. The 2 groups showed no significant difference in the level of urbanization.

10.1371/journal.pone.0057926.t001

###### Demographic characteristics of patients with and without epilepsy.

![](pone.0057926.t001){#pone-0057926-t001-1}

  Variables       Epilepsy   *p* value[\*](#nt101){ref-type="table-fn"}                
  -------------- ---------- -------------------------------------------- ------ ------ ------
  Age, years                                                                           
  Mean ± SD        8±5.35                      8±5.34                     0.86         
  0--6              4274                        43.6                      1082   43.8   0.98
  6--12             3056                        31.2                      766    31.0  
  12--18            2480                        25.3                      620    25.1  
  Sex                                                                                  
  Female            4306                        43.9                      1083   43.9   0.98
  Male              5504                        56.1                      1385   56.1  
  Urbanization                                                                         
  1 (highest)       2653                        27.0                      659    26.7   0.60
  2                 2968                        30.3                      750    30.4  
  3                 1894                        19.3                      482    19.5  
  4 (lowest)        2252                        23.0                      569    23.1  

Chi-square test except for the *P* value of age, according to a Wilcoxon two-sample test.

During the median follow-up of 7.0 years for the epilepsy group and 7.5 years for the comparison group, the incidence of ADHD (per 1000 person-years) was 7.76 and 3.22, respectively ([Table 2](#pone-0057926-t002){ref-type="table"}). Epilepsy is associated with an increased risk of subsequent ADHD (adjusted HR 2.54, 95% CI: 2.02--3.18). The age-specific HRs increased with age, at 2.26 (95% CI: 1.74--2.94), 3.53 (95% CI: 2.15--5.80), and 5.30 (95% CI: 1.42--19.78) for patients aged 0--6 years, 6--12 years, and 12--18 years, respectively. Both sexes showed an association between epilepsy and subsequent risk of ADHD.

10.1371/journal.pone.0057926.t002

###### Hazard ratios for ADHD incidence with epilepsy.

![](pone.0057926.t002){#pone-0057926-t002-2}

                Non-epilepsy comparisongroup   Patients withepilepsy   Hazard ratio and 95% CI                                                                                          
  ------------ ------------------------------ ----------------------- ------------------------- ----- ------- ------- ------ --------------------------------------------------- ------ ---------------------------------------------------
  All                       205                        63695                    3.22             121   15585   7.76    2.52   (2.01--3.17)[\*\*\*](#nt107){ref-type="table-fn"}   2.54   (2.02--3.18)[\*\*\*](#nt107){ref-type="table-fn"}
  Age, years                                                                                                                                                                            
  0--6                      159                        32437                    4.90             87    7944    10.95   2.26   (1.74--2.93)[\*\*\*](#nt107){ref-type="table-fn"}   2.26   (1.74--2.94)[\*\*\*](#nt107){ref-type="table-fn"}
  6--12                      34                        17328                    1.96             29    4236    6.85    3.50   (2.13--5.74)[\*\*\*](#nt107){ref-type="table-fn"}   3.53   (2.15--5.80)[\*\*\*](#nt107){ref-type="table-fn"}
  12--18                     4                         13822                    0.29              5    3405    1.47    5.13    (1.38--19.09)[\*](#nt105){ref-type="table-fn"}     5.30    (1.42--19.78)[\*](#nt105){ref-type="table-fn"}
  Sex                                                                                                                                                                                   
  Female                     34                        28091                    1.21             30    6949    4.32    3.59   (2.19--5.86)[\*\*\*](#nt107){ref-type="table-fn"}   3.59   (2.20--5.86)[\*\*\*](#nt107){ref-type="table-fn"}
  Male                      171                        35604                    4.80             91    8636    10.54   2.31   (1.79--2.99)[\*\*\*](#nt107){ref-type="table-fn"}   2.31   (1.78--2.98)[\*\*\*](#nt107){ref-type="table-fn"}

Note: PY, person-years at risk.

Adjusted for age, sex and urbanization level.

per1,000 person-years.

*P*\< .05;

*P*\< .01;

*P*\< .0001.

Cohort 2: ADHD and Subsequent Risk of Epilepsy {#s3b}
----------------------------------------------

Cohort 2 included 3664 ADHD and 14 522 non-ADHD children ([Table 3](#pone-0057926-t003){ref-type="table"}). More than half (64.3%) of the ADHD group was aged 6--12 years, and 22.4% were aged 0--6 years. The mean age (±SD) was 8.7 ± 3.0 years, with male predominance in the ADHD group (80.2%). The ADHD and comparison groups were matched for age and sex. Children with ADHD were more likely to reside in urbanized areas than those in the comparison group (*P* \< .0001).

10.1371/journal.pone.0057926.t003

###### Demographic characteristics of ADHD and non-ADHD patients.

![](pone.0057926.t003){#pone-0057926-t003-3}

  Variables        ADHD     *P* value[\*](#nt108){ref-type="table-fn"}                
  -------------- --------- -------------------------------------------- ------ ------ ----------
  Age, years                                                                          
  Mean ± SD       8.7±3.0                    8.7±3.0                     0.66         
  0--6             3230                        22.2                      821    22.4     0.99
  6--12            9348                        64.4                      2357   64.3  
  12--18           1944                        13.4                      486    13.3  
  Sex                                                                                 
  Female           2908                        20.0                      727    19.8     0.80
  Male             11614                       80.0                      2937   80.2  
  Urbanization                                                                        
  1 (highest)      3870                        26.6                      1370   37.4   \<0.0001
  2                4311                        29.7                      1155   31.5  
  3                2925                        20.1                      640    17.5  
  4 (lowest)       3353                        23.1                      484    13.2  

Chi-square test except for the *P* value of age, according to a Wilcoxon two-sample test.

During the median follow-up period of 3.3 years for the ADHD group and 3.5 years for the comparison group, the incidence of epilepsy (per 1000 person-years) was 3.24 and 0.78, respectively ([Table 4](#pone-0057926-t004){ref-type="table"}). Children with ADHD had a 3.94-fold risk of developing epilepsy (95% CI: 2.58--6.03) after controlling for age, sex, and level of urbanization relative to the comparison group. There was an association among patient subgroups stratified by age and sex, but the HR was not significantly different among age groups and between male and female patients.

10.1371/journal.pone.0057926.t004

###### Hazard ratios for the incidence of epilepsy with ADHD.

![](pone.0057926.t004){#pone-0057926-t004-4}

                Non-ADHD comparison group   Patients with ADHD   Hazard ratio and 95% CI                                                                                        
  ------------ --------------------------- -------------------- ------------------------- ---- ------- ------ ------ --------------------------------------------------- ------ ---------------------------------------------------
  All                      43                     55125                   0.78             44   13600   3.24   4.14   (2.72--6.31)[\*\*\*](#nt114){ref-type="table-fn"}   3.94   (2.58--6.03)[\*\*\*](#nt114){ref-type="table-fn"}
  Age, years                                                                                                                                                                    
  0--6                     16                     17395                   0.92             16   4294    3.73   4.09   (2.05--8.19)[\*\*\*](#nt114){ref-type="table-fn"}   3.79    (1.88--7.62)[\*\*](#nt113){ref-type="table-fn"}
  6--12                    20                     32190                   0.62             21   7942    2.64   4.20   (2.28--7.76)[\*\*\*](#nt114){ref-type="table-fn"}   4.16   (2.24--7.74)[\*\*\*](#nt114){ref-type="table-fn"}
  12--18                    7                      5541                   1.26             7    1364    5.13   4.07   (1.43--11.62)[\*\*](#nt113){ref-type="table-fn"}    3.84    (1.32--11.14)[\*](#nt112){ref-type="table-fn"}
  Sex                                                                                                                                                                           
  Female                   10                     10544                   0.95             11   2581    4.26   4.47   (1.90--10.54)[\*\*](#nt113){ref-type="table-fn"}    4.44   (1.86--10.61)[\*\*](#nt113){ref-type="table-fn"}
  Male                     33                     44581                   0.74             33   11018   2.99   4.04   (2.49--6.54)[\*\*\*](#nt114){ref-type="table-fn"}   3.81   (2.34--6.21)[\*\*\*](#nt114){ref-type="table-fn"}

Note: PY, person-years at risk.

Adjusted for age, sex and urbanization level.

per1,000 person-years.

*P*\< .05;

*P*\< .01;

*P*\< .0001.

Discussion {#s4}
==========

The prevalence rates of ADHD and epilepsy in the general pediatric population are 3%--7% and 0.05%--1%, respectively [@pone.0057926-Cowan1]--[@pone.0057926-1]. The rate of the 2 occurring together is greater than that expected by chance because ADHD and seizures may be comorbid conditions. Part of this increase is a bidirectional relationship between ADHD and epilepsy. In this study, the possibility of developing ADHD among epileptic patients is higher (adjusted HR 2.54, 95% CI: 2.02--3.18). Conversely, ADHD increases the risk of subsequent epilepsy (adjusted HR 3.94, 95% CI: 2.58--6.03), and vice versa.

The complex relationship between epilepsy and ADHD remains unclear. Researchers have proposed several hypotheses on the possible pathophysiology of their comorbidity in the context of brain development, including the effects of chronic seizures, EEG epileptiform discharges, and AEDs [@pone.0057926-Aldenkamp1], [@pone.0057926-SemrudClikeman1]. Neurodevelopmental conditions may increase the vulnerability of children to epilepsy and ADHD. In a retrospective study, Austin et al showed that attention and behavioral problems are higher in children with epilepsy compared to their siblings 6 months prior to the first diagnosed seizure. This finding is consistent with the hypothesis that the possibility of acquiring ADHD increases in epileptic children and is independent of the effects of seizures or their treatment [@pone.0057926-Austin2]. Hesdorffer et al evaluated ADHD symptoms in children prior to the onset of seizures, showing that ADHD is significantly more common in patients with new-onset epilepsy (31%) than in healthy controls (6%). For example, ADHD antedated the diagnosis of epilepsy in 82% of cases [@pone.0057926-Hesdorffer1].

The pathogenesis of the relationship between epilepsy and ADHD remains unknown. A frontostriatal network dysfunction is related to ADHD without epilepsy [@pone.0057926-Bush1]--[@pone.0057926-Zang1], whereas evidence of frontal lobe dysfunction appears in both focal-onset and the generalized-onset types of epilepsy. Thus, the frontal lobes may correlate between epilepsy and ADHD. Their comorbidity is also supported by animal models, which may shed light on the common genetic defects underlying these disorders. In one study, rats were selectively bred to test amygdala kindling (a model for temporal lobe epilepsy) speed. The same rats were assessed for ADHD-like symptoms in subsequent generations. The fast kindling rats (genetically seizure prone) were similar to humans with ADHD compared to the slow kindling rats [@pone.0057926-McIntyre1]. Another study shows that seizure-induced rats simultaneously developed behavioral and physical characteristics similar to ADHD symptoms [@pone.0057926-Gilby1].

The results of this study show that common neurobiological mechanisms may be present in epilepsy and ADHD. Identifying these mechanisms is an important consideration in the clinical management of epilepsy. Further studies should investigate genetic abnormalities that, through variable penetrance, can lead to epilepsy alone, epilepsy with ADHD, or ADHD alone. The effects of epileptiform activity in different neural network functions also require better understanding.
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